All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - ANA
Novel biomarkers in the management of Systemic Sclerosis
Read more...
Practical Application of viscoelastic testing in managing COVID-19 patients
Read more...
D3 - Session 6 - D-Dimer and Sepsis
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 4 - D-Dimer in Cancer and VTE
Read more...
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Ionized calcium measurements during continuous renal replacement therapy with regional citrate anticoagulation
Read more...
Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device
Read more...
Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device
Read more...
Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value
Read more...
Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device
Read more...
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response
Read more...
Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis
Read more...
Antiplatelet Therapy in Flow Diversion
Read more...
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping
Read more...
Treatment of Bilateral Giant Fusiform Petrocavernous Aneurysms
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Read more...
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Read more...
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration
Read more...
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Read more...
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
How do we manage cardiopulmonary bypass coagulopathy?
Read more...
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study
Read more...
Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
Read more...
The absorption of aspirin is reduced after coronary artery bypass grafting
Read more...
Evaluating the effectiveness of pre-operative platelet inhibition testing to reduce costs and pre-operative length of stay
Read more...
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Assessment of platelet function after discontinuation of ticagrelor
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Read more...
Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention
Read more...
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
Read more...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
Using heparin molecules to manage COVID-2019
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
Read more...
D-dimer Triage for COVID-19
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
Read more...
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Read more...
https://pubmed.ncbi.nlm.nih.gov/32339221/
Read more...
Hematological findings and complications of COVID-19
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
COVID‐19: A collision of complement, coagulation and inflammatory pathways
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study
Read more...
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Read more...
COVID-19 and acute coagulopathy in pregnancy
Read more...
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Read more...
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
Read more...
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Read more...
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Read more...
Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Read more...
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Read more...
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis
Read more...
Start
Prev
1
2
3
4
Next
End
Page 2 of 4
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection